第十六届东方心脏病学会议(OCC 2022)线上会议直播回放 5月27日 云上东方17 第1-4节
肿瘤心脏病学论坛
第1节 肿瘤心脏病学前沿速递1


主持(Moderator)
程蕾蕾 (上海)Cheng Lei-Lei (Shanghai)
张志仁 (黑龙江)Zhang Zhi-Ren (Heilongjiang)
商洪才 (北京)Shang Hong-Cai (Beijing)
于韬 (辽宁)Yu Tao (Liaoning)
沈玲红 (上海)Shen Ling-Hong (Shanghai)
王群山 (上海)Wang Qun-Shan (Shanghai)
08:30-08:45
·肿瘤心脏病学的发展历程和热点问题
·Development history and hot topics in Cardio-Oncology
李悦 (黑龙江)Li Yue (Heilongjiang)
08:45-09:00
·心脏和癌症医生:跨界治疗的时刻
·Cardiologist and Oncologist: Time to Cross the Bridge
张玉蛟 (美国)Joe Y. Chang (USA)
09:00-09:15
·免疫检查点抑制剂心脏毒性管理的挑战和治疗对策
·Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors
张旭敏 (上海)Zhang Xu-Min (Shanghai)
09:15-09:30
·免疫检查点抑制剂相关心脏毒性临床实践认识与思考
·Cardiotoxicity associated with immune checkpoint inhibitors:clinical practice and considerations
王延风 (北京)Wang Yan-Feng (Beijing)
09:30-09:45
·CMR看肿瘤心脏病心血管毒性--从2021ESC ICOS共识意见说起
·Tumor cardiotoxicity in heart disease from CMR -- from 2021ESC
姜萌 (上海)Jiang Meng (Shanghai)
09:45-10:00
·肿瘤药物相关性高血压的诊治进展
·Progress in diagnosis and treatment of tumor drug-associated hypertension
卜培莉 (山东)Bu Pei-Li (Shandong)
10:00-10:15
·放射治疗引起的心血管表现:国际专家共识和国内实践
·Cardiovascular manifestations induced by radiation therapy: international expert consensus and domestic practice
陈佳艺 (上海)Chen Jia-Yi (Shanghai)
10:15-10:30
放疗联合免疫治疗的心脏损伤
Cardiac damage in radiotherapy combined with immunotherapy
王军 (河北)Wang Jun (Hebei)
第2节 肿瘤心脏病学前沿速递2
Session2 New progress of Cardio-Oncology


主持(Moderator)
方唯一 (上海)Fang Wei-Yi (Shanghai)
魏盟 (上海)Wei Meng (Shanghai)
马飞 (北京)Ma Fei (Beijing)
张宇辉 (北京)Zhang Yu-Hui (Beijing)
刘彤 (天津)Liu Tong (Tianjin)
沈伟 (上海)Shen Wei (Shanghai)
10:40-10:55
·GRK4在TKI抗肿瘤药致高血压发生中的作用机制研究
·Mechanism of renal GRK4 in TKI induced hypertension
曾春雨 (重庆)Zeng Chun-Yu (Chongqing)
10:55-11:10
·蒽环类药物心脏毒性早期评估研究进展
·Progress in early assessment of cardiotoxicity of anthracyclines
姜永生 (湖北)Jiang Yong-Sheng (Hubei)
11:10-11:25
·以心肌应变为导向的肿瘤心脏病学现状和未来发展方向
·Current status and future development of cardiac strain - oriented tumor cardiology
尹立雪 (四川)Yin Li-Xue (Sichuan)
11:25-11:40
·心脏淀粉样变性多模态成像进展
·Update on Multimodality imaging of cardiac amyloidosis
郑景生 (美国)Zheng Jing-Sheng (USA)
11:40-11:55
·免疫检查点抑制剂相关性心肌炎合并肌炎/重症肌无力的早期识别及治疗
·Early recognition and treatment of Immune checkpoint inhibitor-induced myocarditis with myositis/myasthenia gravis overlap syndrome
方凤奇 (辽宁)Fang Feng-Qi (Liaoning)
11:55-12:10
乳腺癌靶向治疗相关心脏毒性防治的研究进展
Advances in the prophylaxis and treatment of cardiotoxicity caused by targeted therapy in breast cancer
翟振华 (辽宁)Zhai Zhen-Hua (Liaoning)
12:10-12:25
·免疫检查点抑制剂与动脉粥样硬化:从机制到临床
·Immune checkpoint inhibitors and Atherosclerosis: from bench to bedside
王阿曼 (辽宁)Wang A-Man (Liaoning)
12:25-12:40
络氨酸激酶(TKI)类靶向药的心血管毒性相关研究进展
Research progress on cardiovascular toxicity of tyrosine kinase (TKI) targeted drugs
沈赞 (上海)Shen Zan (Shanghai)
第一三共午间卫星会


主席(Chairman)
夏云龙 (辽宁)Xia Yun-Long (Liaoning)
12:50-12:55
·主席开场致辞
夏云龙 (辽宁)Xia Yun-Long (Liaoning)
12:55-13:15
·肿瘤患者的抗凝策略
邵群 (黑龙江)Shao Qun (Heilongjiang)
13:15-13:35
·口服抗凝药患者出血管理策略
张宇辉 (北京)Zhang Yu-Hui (Beijing)
13:35-13:45
·全体讨论
13:45-13:50
·总结
夏云龙 (辽宁)Xia Yun-Long (Liaoning)
第3节 中国肿瘤心脏病学“原创研究英雄榜”1


Session 3 Cardio-Oncology: New Voice of China
主持(Moderator)
程蕾蕾 (上海)Cheng Lei-Lei (Shanghai)
夏云龙 (辽宁)Xia Yun-Long (Liaoning)
刘斌 (吉林)Liu Bin (Jilin)
张梅 (山东)Zhang Mei (Shandong)
孙刚 (新疆)Sun Gang (Xinjiang)
刘海霞 (重庆)Liu Hai-Xia (Chongqing)
14:00-14:15
开幕式
程蕾蕾 (上海)Cheng Lei-Lei (Shanghai)
14:15-14:30
·肿瘤心脏病的预防策略
·Prevention Strategies for Cardio-Oncology
Susan Dent (美国)Susan Dent (USA)
14:30-14:45
阿霉素致心血管毒性的机制:不止作用于心肌细胞
Doxorubicin contributes to cardiovascular toxicity by interfering with platelet function
杨柳 (辽宁)Yang Liu (Liaoning)
14:45-15:00
·多柔比星的心脏损害
·Doxorubicin associated cardiac damage
张英梅 (上海)Zhang Ying-Mei (Shanghai)
15:00-15:15
·肿瘤心脏病的相关标志物检测及其应用
·Detection and application of cardio-oncology related biomarkers
卢仁泉 (上海)Lu Ren-Quan (Shanghai)
15:15-15:30
·乳腺癌抗肿瘤治疗相关的左室壁节段性功能受损
·Segmental impairment of left ventricular wall associated with antitumor therapy in breast cancer
丛涛 (辽宁)Cong Tao (Liaoning)
15:30-15:45
DLBCL中蒽环类药物心脏毒性预测的探索
Prediction of cardiotoxicity of anthracyclines treating with DLBCL
张群岭 (上海)Zhang Qun-Ling (Shanghai)
15:45-16:00
·肿瘤与房颤—真实世界研究
·Tumor and Atrial Fibrillation—Real World Research
曾军 (上海)Zeng Jun (Shanghai)
第4节 中国肿瘤心脏病学“原创研究英雄榜”2


Session 4 Cardio-Oncology: New Voice of China
主持(Moderator)
朱天刚 (北京)Zhu Tian-Gang (Beijing)
卜军 (上海)Bu Jun (Shanghai)
赵健元 (上海)Zhao Jian-Yuan (Shanghai)
许迪 (江苏)Xu Di (Jiangsu)
黄辉 (广东)Huang Hui (Guangdong)
李晓宇 (上海)Li Xiao-Yu (Shanghai)
16:00-16:15
CSCO指南解读
Interpretation of CSCO guidelines
刘基巍 (辽宁)Liu Ji-Wei (Liaoning)
16:15-16:30
·肿瘤高血压病学新进展-机遇与挑战
·New Advances in Oncohypertension - Opportunities and Challenges
钟久昌 (北京)Zhong Jiu-Chang (Beijing)
16:30-16:45
无创神经调节预防阿霉素引起的心脏毒性
Noninvasive neuromodulation to prevent doxorubicin-induced cardiotoxicity
余锂镭 (湖北)Yu Li-Lei (Hubei)
16:45-17:00
肿瘤免疫治疗相关的心脏毒性特点分析
The characteristics of cardiotoxicity related to cancer immunotherapy
韩森 (北京)Han Sen (Beijing)
17:00-17:15
·肿瘤与肺血栓栓塞
·Cancer and pulmonary thromboembolism
唐红 (四川)Tang Hong (Sichuan)
17:15-17:30
·从风湿免疫角度看免疫性心肌炎临床诊治进展
·Progress in clinical diagnosis and treatment of immune myocarditis from rheumatology
陈慧勇 (上海)Chen Hui-Yong (Shanghai)
17:30-17:45
肿瘤心脏病学实践中的创新转化
Innovative transformation in the practice of Cardiology-Oncology
程蕾蕾 (上海)Cheng Lei-Lei (Shanghai)
最后编辑于 2023-03-07 · 浏览 734